Genomic Testing

Early results from a study of genomewide sequencing support the promise of using plasma cell–free DNA (cfDNA) to develop an early cancer detection test with high specificity, said Geoffrey R. Oxnard, MD, Thoracic Oncologist, Dana-Farber Cancer Institute, Boston, at ASCO 2018.

Results 1 - 1 of 1
  •  Association for Value-Based Cancer Care
  • Oncology Practice Management
  • Value-Based Cancer Care
  • Value-Based Care in Rheumatology
  • Rheumatology Practice Management
  • Urology Practice Management
  • Lynx CME